(Q33701381)

English

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 July 2017

Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial (English)

1 reference

Europe PubMed Central

28 July 2017

multiple myeloma

1 reference

based on heuristic

inferred from title

peripheral neuropathy

1 reference

based on heuristic

inferred from title

Pieter Sonneveld

13

object named as

Pieter Sonneveld

1 reference

Europe PubMed Central

28 July 2017

Hartmut Goldschmidt

12

object named as

Hartmut Goldschmidt

1 reference

Europe PubMed Central

28 July 2017

Henk M. Lokhorst

10

object named as

Henk M Lokhorst

1 reference

Europe PubMed Central

28 July 2017

Bronno van der Holt

4

object named as

Bronno van der Holt

1 reference

Europe PubMed Central

28 July 2017

11

object named as

Brian G Durie

1 reference

Europe PubMed Central

28 July 2017

author name string

Annemiek Broyl

1

1 reference

Europe PubMed Central

28 July 2017

Sophie L Corthals

2

1 reference

Europe PubMed Central

28 July 2017

Joost Lm Jongen

3

1 reference

Europe PubMed Central

28 July 2017

Rowan Kuiper

5

1 reference

Europe PubMed Central

28 July 2017

Yvonne de Knegt

6

1 reference

Europe PubMed Central

28 July 2017

Mark van Duin

7

1 reference

Europe PubMed Central

28 July 2017

Laila el Jarari

8

1 reference

Europe PubMed Central

28 July 2017

Uta Bertsch

9

1 reference

Europe PubMed Central

28 July 2017

publication date

21 September 2010

1 reference

Europe PubMed Central

28 July 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

28 July 2017

11

1 reference

Europe PubMed Central

28 July 2017

11

1 reference

Europe PubMed Central

28 July 2017

1057-1065

1 reference

Europe PubMed Central

28 July 2017

Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study of two doses of bortezomib in relapsed or refractory myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

A phase 2 study of bortezomib in relapsed, refractory myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Management of treatment-related adverse events in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantitative Sensory Findings in Patients With Bortezomib-Induced Pain

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib-induced peripheral neurotoxicity: a neurophysiological and pathological study in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondrial-mediated disregulation of Ca2+ is a critical determinant of Velcade (PS-341/bortezomib) cytotoxicity in myeloma cell lines

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune-mediated neuropathies in myeloma patients treated with bortezomib

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Neuropathies associated with paraproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-agent bortezomib in previously untreated multiple myeloma: efficacy, characterization of peripheral neuropathy, and molecular correlations with response and neuropathy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib in the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib or high-dose dexamethasone for relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

PLINK: a tool set for whole-genome association and population-based linkage analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

RhoBTB2 (DBC2) is a mitotic E2F1 target gene with a novel role in apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Bortezomib, but not cisplatin, induces mitochondria-dependent apoptosis accompanied by up-regulation of noxa in the non-small cell lung cancer cell line NCI-H460.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

The proteasome inhibitor bortezomib induces apoptosis in human retinoblastoma cell lines in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Predisposing genetic factors for diabetic polyneuropathy in patients with type 1 diabetes: a population-based case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of plasminogen activator inhibitor-1 and -2 in dorsal root ganglion neurons after peripheral nerve injury

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Phosphorylation states of cell cycle and DNA repair proteins can be altered by the nsSNPs

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of germline GLI1 variation implicates hedgehog signalling in the regulation of intestinal inflammatory pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970206-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(10)70206-0

1 reference

Europe PubMed Central

28 July 2017

1 reference

Europe PubMed Central

28 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33701381&oldid=2076604532"